FibroGen, Inc.FGENNASDAQ
LOADING
|||
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 2738.91% |
| Q2 2025 | -263.89% |
| Q1 2025 | -74.20% |
| Q4 2024 | 205.26% |
| Q3 2024 | -9.91% |
| Q2 2024 | 52.80% |
| Q1 2024 | 41.43% |
| Q4 2023 | 11.61% |
| Q3 2023 | 27.45% |
| Q2 2023 | -14.31% |
| Q1 2023 | -15.91% |
| Q4 2022 | 27.80% |
| Q3 2022 | -26.20% |
| Q2 2022 | -14.90% |
| Q1 2022 | 52.86% |
| Q4 2021 | -369.25% |
| Q3 2021 | 137.17% |
| Q2 2021 | -86.73% |
| Q1 2021 | -22.38% |
| Q4 2020 | -277.66% |
| Q3 2020 | 138.69% |
| Q2 2020 | -8.89% |
| Q1 2020 | 20.15% |
| Q4 2019 | -98.47% |
| Q3 2019 | -142.62% |
| Q2 2019 | 355.45% |
| Q1 2019 | -316.73% |
| Q4 2018 | 149.24% |
| Q3 2018 | -81.71% |
| Q2 2018 | 43.42% |
| Q1 2018 | -87.13% |
| Q4 2017 | 41.38% |
| Q3 2017 | -13.72% |
| Q2 2017 | -0.07% |
| Q1 2017 | 2.47% |
| Q4 2016 | -40.77% |
| Q3 2016 | -199.33% |
| Q2 2016 | 187.34% |
| Q1 2016 | 45.80% |
| Q4 2015 | -13.91% |